1. 6) Swerdlow SH, Campo E, eds: Immunodeficiencyassociated lymphoproliferative disorders. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008, p335-351.
2. 7) Yoneda T, Hagino H, et al : Bisphosphonate-related osteonecrosis of the jaw: position paper from the allied task force committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28: 365-383, 2010.
3. 8) Smolen JS, Atetaha D, et al : Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69: 631-637, 2009.
4. 9) Ellman MH, Hurwitz H, et al : Lymphoma developing in a patients with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741-1743, 1991.
5. 10) Harris NL, Swerdlow SH, et al : Methotrexate-associated lymphoproliferative disorders. In Jaffe ES, Harris NL, eds; World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001, p270-271.